Stretching the mutant prevention concentration (MPC) beyond its limits

被引:52
作者
Smith, HJ
Nichol, KA
Hoban, DJ
Zhanel, GG
机构
[1] Hlth Sci Ctr, Dept Clin Microbiol, Winnipeg, MB R3A 1R9, Canada
[2] Univ Manitoba, Fac Med, Dept Med Microbiol, Winnipeg, MB R3T 2N2, Canada
[3] Hlth Sci Ctr, Dept Med, Winnipeg, MB R3A 1R9, Canada
关键词
mutant prevention concentration; resistance mechanisms;
D O I
10.1093/jac/dkg255
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
[No abstract available]
引用
收藏
页码:1323 / 1325
页数:3
相关论文
共 8 条
[1]  
AKINS RL, 2002, 42 INT C ANT AG CHEM, P10
[2]   Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae [J].
Blondeau, JM ;
Zhao, XL ;
Hansen, G ;
Drlica, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :433-438
[3]   Mutant prevention concentration as a measure of antibiotic potency:: Studies with clinical isolates of Mycobacterium tuberculosis [J].
Dong, YZ ;
Zhao, XL ;
Kreiswirth, BN ;
Drlica, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2581-2584
[4]   Molecular detection of antimicrobial resistance [J].
Fluit, AC ;
Visser, MR ;
Schmitz, FJ .
CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (04) :836-871
[5]  
FRENCH GL, 1997, ANTIBIOT CHEMOTHER, P23
[6]  
GUERRINI N, 2002, 6 INT C MACR AZ STRE, P107
[7]  
Kucer A, 1997, USE ANTIBIOTICS CLIN, V5th, P3
[8]   Restricting the selection of antibiotic-resistant mutant bacteria: Measurement and potential use of the mutant selection window [J].
Zhao, XL ;
Drlica, K .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (04) :561-565